Upon stimulation, we observed an increase of ADAM17 in HT1080 cells, and no significant change in the Hodgkin’s lymphoma cell line L248, HeLa cells, U266B1 myeloma cells, Panc89 or Jurkat variants. This evidence concerns the gene ADAM17 and plasma cell myeloma.